HZHengyu Zhao

Hengyu Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hengyu Zhao has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Chunrong Ju

    Department of Organ Transplantation, State Key laboratory of Respiratory Disease, National Clinical Research Center for kespiratory Diseae, Guangzhou institute of Respiratory Health The First Affiliated Hospital of Guangzhou Medical University Guangzhou Guangdong China

    2 shared publications
  • Chen-Zhuo Feng

    Department of Medical Morphology, School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, China

    1 shared publication
  • Hua-Juan Ruan

    Department of Pathology, Lin'an People's Hospital Affiliated to Hangzhou Medical College, Hangzhou, China

    1 shared publication
  • Jiaqi Chen

    State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China

    1 shared publication
  • Jie Zhang

    Department of Organ Transplantation, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health the First Affiliated Hospital of Guangzhou Medical University Guangzhou China

    1 shared publication
  • Jun-Jie Fan

    Department of Pathology, Lin'an People's Hospital Affiliated to Hangzhou Medical College, Hangzhou, China

    1 shared publication

Latest Publications

  • A Case of Guillain–Barré Syndrome Complicated by Refractory Cytomegalovirus Disease

    by Hengyu Zhao, Wenshan Zhong, Lulin Wang, Qiaoyan Lian, Jie Zhang, Chunrong Ju

  • Open Access

    Investigation of Risk Factors and Development of Clinical Prediction Model for Nocardiosis in Lung Transplant Recipients

    by Hengyu Zhao, Zhibin Xu, Xiaohua Wang, Yu Xu, Yi Lu, Jiaqi Chen, Qiaoyu Ye, Xuan Li, Yanhua Wen, Chunrong Ju

    Purpose: Nocardiosis is an opportunistic infection in lung transplant recipients but is often misdiagnosed or overlooked. This study aimed to identify risk factors and develop an effective predictive model for nocardiosis in this population. Patients and Methods: This single-center retrospective study analyzed 679 lung transplant recipients from January 1, 2015, to July 9, 2024. Twenty patients with nocardiosis were compared with 40 matched controls. Feature selection was performed using LASSO regression, and logistic regression identified risk factors. Model performance was assessed via ROC curves, calibration curves, and decision curve analysis. Results: Decreased CD4+ T cells, elevated CD8+ T cells, and reduced IgA levels were significantly associated with nocardiosis (P < 0.05). The model incorporating these factors demonstrated strong predictive ability with an area under the ROC curve of 0.955. Conclusion: CD4+ T cells, CD8+ T cells, and IgA are independent risk factors for nocardiosis post-lung transplantation. The developed model effectively distinguishes nocardiosis cases, aiding early clinical identification.

  • Prognostic Role of Mitochondrial Transcription Termination Factor 3 in Thyroid Carcinoma

    by Mei-Tao Sun, Heng-Yu Zhao, Hua-Juan Ruan, Li-Hui Yu, Ming-Li Guan, Jun-Jie Fan, Chen-Zhuo Feng, Yang-Yun Lou

    Background: Studies have shown that the Mitochondrial Transcription Termination Factor 3 (MTERF3) negatively regulates mitochondrial gene expression and energy metabolism, and plays a significant role in many cancer types. Nevertheless, the expression and prognostic role of MTERF3 in patients with thyroid carcinoma (THCA) is still unclear. Thus, we investigated the expression, clinicopathological significance, and prognostic value of MTERF3 in THCA. Methods: The protein and mRNA expression levels of MTERF3 were, respectively, analyzed using immunohistochemistry (IHC) from THCA tissues and RNA-Seq data downloaded from The Cancer Genome Atlas. In addition, the relationships among the expression of MTERF3, the stemness feature, the extent of immune infiltration, drug sensitivity, the expression of ferroptosis, and N6-methyladenosine (m6A) methylation regulators, were evaluated as prognostic indicators for patients with THCA using the Kaplan-Meier plotter database. Results: The IHC and RNAseq results showed that the protein and mRNA expression levels of MTERF3 in adjacent nontumor tissues were significantly higher than in THCA tissues. The survival analysis indicated that decreased expression of MTERF3 was associated with a poorer prognosis. Furthermore, the expression of MTERF3 not only negatively correlated with the enhancement of the stemness of THCA and the reduction of drug sensitivity but also was implicated in ferroptosis and m6A methylation. Conclusion: The data from this study support the hypothesis that decreased expression of MTERF3 in THCA is associated with a poor prognosis.